GGrantIndex
← Search

TAMOXIFEN &RALOXIFENE FOR PREVENTTION OF BREAST CANCER

$0M01FY2000RRNIH

University Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials

Abstract

The purpose of this research study is to find out: 1) Is raloxifene, also known by the trade name Evista, effective in reducing the incidence of breast cancer in women who are at increased risk for developing cancer? 2) If it is effective, how does raloxifene compare to tamoxifen, also known as Nolvadex, in reducing the incidence of breast cancer? 3) How do the side effects (good and bad) of raloxifene and tamoxifen compare?

View original record on NIH RePORTER →